Cholesterol-Lowering Meds Fight Pneumonia

Hospitalized statin users nearly three times less likely to die, study finds

Please note: This article was published more than one year ago. The facts and conclusions presented may have since changed and may no longer be accurate. And "More information" links may no longer work. Questions about personal health should always be referred to a physician or other health care professional.

En Español

MONDAY, July 25, 2005 (HealthDay News) -- Cholesterol-busting drugs called statins can also reduce the risk of death by pneumonia in hospitalized patients, according to a study in the journal Respiratory Research.

Researchers found that pneumonia patients who were taking a statin (which include drugs such as Lipitor, Pravachol, and Zocor) when they entered the hospital were 2.8 times less likely to die than patients who were not on these drugs.

Statins are known to affect the immune system, and that could explain their effect on pneumonia patients, speculate researchers from the University of Texas Health Science Center at San Antonio.

Pneumonia is the leading cause of death from infection in the United States, killing up to 40,000 people every year.

More information

The National Institutes of Health has more about pneumonia.

SOURCES: Respiratory Research, news release, July 25, 2005


Last Updated: